OptiNose Stock Target Price and Analyst Consensus

OPTN Stock  USD 0.89  0.04  4.30%   
The current analyst and expert consensus on OptiNose is Strong Buy, with 2 strong buy opinions. The current projected OptiNose target price consensus is 3.00 with 4 analyst opinions. The most common way OptiNose analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview OptiNose executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on OptiNose. We encourage you to use your own analysis of OptiNose to validate this buy or sell advice. OptiNose buy-or-sell recommendation module provides average expert sentiment on the projected OptiNose target price to derive its highest and lowest estimates based on its projected price volatility. Check out Macroaxis Advice on OptiNose to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
To learn how to invest in OptiNose Stock, please use our How to Invest in OptiNose guide.
Lowest Forecast
2.73
Highest Forecast
3.33
Target Price
3
As of the 19th of April 2024, Gross Profit is likely to drop to about 38.9 M. In addition to that, Pretax Profit Margin is likely to drop to -0.52. At this time, OptiNose's Cash is very stable compared to the past year. As of the 19th of April 2024, Cash And Short Term Investments is likely to grow to about 129.3 M, while Short and Long Term Debt Total is likely to drop about 93.6 M.
  
It's important to approach OptiNose's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize OptiNose price targets

OptiNose's stock target price is an estimate of its future price, usually made by analysts. Using OptiNose's target price to determine if it is a suitable investment can be done through the following steps:
  • Look at OptiNose's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if OptiNose's stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional OptiNose Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of OptiNose is a key component of OptiNose valuation and have some predictive power on the future returns of a OptiNose.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of OptiNose's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.050.945.44
Details
Intrinsic
Valuation
LowRealHigh
0.071.445.94
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.12-0.11-0.09
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as OptiNose. Your research has to be compared to or analyzed against OptiNose's peers to derive any actionable benefits. When done correctly, OptiNose's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in OptiNose.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
FinTech Idea
FinTech
Invested over 70 shares
Chemicals Idea
Chemicals
Invested over 40 shares
Driverless Cars Idea
Driverless Cars
Invested over 200 shares
Banking Idea
Banking
Invested over 30 shares
Blockchain Idea
Blockchain
Invested few shares
Automobiles and Trucks Idea
Automobiles and Trucks
Invested over 200 shares
Macroaxis Index Idea
Macroaxis Index
Invested few shares
When determining whether OptiNose offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of OptiNose's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Optinose Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Optinose Stock:
Check out Macroaxis Advice on OptiNose to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
To learn how to invest in OptiNose Stock, please use our How to Invest in OptiNose guide.
You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Complementary Tools for OptiNose Stock analysis

When running OptiNose's price analysis, check to measure OptiNose's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OptiNose is operating at the current time. Most of OptiNose's value examination focuses on studying past and present price action to predict the probability of OptiNose's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OptiNose's price. Additionally, you may evaluate how the addition of OptiNose to your portfolios can decrease your overall portfolio volatility.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Stocks Directory
Find actively traded stocks across global markets
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
The data published in OptiNose's official financial statements usually reflect OptiNose's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of OptiNose. For example, before you start analyzing numbers published by OptiNose accountants, it's critical to develop an understanding of what OptiNose's liquidity, profitability, and earnings quality are in the context of the Pharmaceuticals space in which it operates.
Please note, the presentation of OptiNose's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, OptiNose's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in OptiNose's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of OptiNose. Please utilize our Beneish M Score to check the likelihood of OptiNose's management manipulating its earnings.